topiramate
NDC 82009-135, topiramate, tablet, film coated, from Quallent Pharmaceuticals Health LLC.
- Product NDC
- 82009-135
- Status
- Listed
- Labeler
- Quallent Pharmaceuticals Health LLC
- Dosage form
- TABLET, FILM COATED
- Route
- ORAL
- Product type
- HUMAN PRESCRIPTION DRUG
- Marketing category
- ANDA
- Application
- ANDA078235
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/82009-135 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- TOPIRAMATE25 mg/1
Pharmacologic classes
Cytochrome P450 2C19 Inhibitors [MoA]; Cytochrome P450 3A4 Inducers [MoA]; Decreased Central Nervous System Disorganized Electrical Activity [PE]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 82009-135-05 | 82009013505 | 500 TABLET, FILM COATED in 1 BOTTLE (82009-135-05) |
Linked data
RxNorm, label and prices
RxNorm concepts
Related lookups
FDA label sections
GET /v1/drugs/labels/9dae6824-6913-42de-b98a-cdcb0d3b4a46NADAC price for package 82009013505
GET /v1/drugs/nadac/82009013505
Use it
Look up 82009-135 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/82009-135 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 82009-135. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.